Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.90−0.03 (-1.55%)
Close on Nov 17, 2026Market cap $18.96MP/E –Yield –
Atossa Therapeutics cash
Cash and short-term investments held at the end of each period.
Atossa Therapeutics's cash was $26.09M at Jun 30, 2026. For fiscal 2025 it was $41.30M, down 41.9% from the year before. Over ten years it grew 27.2% a year on average. The highest annual figure on record is $136.38M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.30M | -41.9% |
| FY2024 | Dec 31, 2024 | $71.08M | -19.6% |
| FY2023 | Dec 31, 2023 | $88.46M | -20.2% |
| FY2022 | Dec 31, 2022 | $110.89M | -18.7% |
| FY2021 | Dec 31, 2021 | $136.38M | +244.8% |
| FY2020 | Dec 31, 2020 | $39.55M | +214.4% |
| FY2019 | Dec 31, 2019 | $12.58M | +21.2% |
| FY2018 | Dec 31, 2018 | $10.38M | +43.8% |
| FY2017 | Dec 31, 2017 | $7.22M | +134.1% |
| FY2016 | Dec 31, 2016 | $3.08M | -17.0% |
| FY2015 | Dec 31, 2015 | $3.72M | -56.3% |
| FY2014 | Dec 31, 2014 | $8.50M | +34.0% |
| FY2013 | Dec 31, 2013 | $6.34M | +267.6% |
| FY2012 | Dec 31, 2012 | $1.73M | -9.7% |
| FY2011 | Dec 31, 2011 | $1.91M | +18536.7% |
| FY2010 | Dec 31, 2010 | $10.25K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $26.09M | -54.9% |
| Q1 FY2026 | Mar 31, 2026 | $31.72M | -51.3% |
| Q4 FY2025 | Dec 31, 2025 | $41.30M | -41.9% |
| Q3 FY2025 | Sep 30, 2025 | $51.85M | -30.7% |
| Q2 FY2025 | Jun 30, 2025 | $57.86M | -27.2% |
| Q1 FY2025 | Mar 31, 2025 | $65.12M | -22.4% |
| Q4 FY2024 | Dec 31, 2024 | $71.08M | -19.6% |
| Q3 FY2024 | Sep 30, 2024 | $74.77M | -20.5% |
| Q2 FY2024 | Jun 30, 2024 | $79.53M | -20.0% |
| Q1 FY2024 | Mar 31, 2024 | $83.96M | -19.2% |
| Q4 FY2023 | Dec 31, 2023 | $88.46M | -20.2% |
| Q3 FY2023 | Sep 30, 2023 | $94.03M | -19.9% |
| Q2 FY2023 | Jun 30, 2023 | $99.39M | -20.8% |
| Q1 FY2023 | Mar 31, 2023 | $103.87M | -21.0% |
| Q4 FY2022 | Dec 31, 2022 | $110.89M | -18.7% |
| Q3 FY2022 | Sep 30, 2022 | $117.37M | -16.2% |
| Q2 FY2022 | Jun 30, 2022 | $125.54M | -11.9% |
| Q1 FY2022 | Mar 31, 2022 | $131.49M | -4.4% |
| Q4 FY2021 | Dec 31, 2021 | $136.38M | +244.8% |
| Q3 FY2021 | Sep 30, 2021 | $140.04M | +1437.9% |
| Q2 FY2021 | Jun 30, 2021 | $142.43M | +1808.6% |
| Q1 FY2021 | Mar 31, 2021 | $137.57M | +1371.2% |
| Q4 FY2020 | Dec 31, 2020 | $39.55M | +214.4% |
| Q3 FY2020 | Sep 30, 2020 | $9.11M | -40.4% |
| Q2 FY2020 | Jun 30, 2020 | $7.46M | -56.3% |
| Q1 FY2020 | Mar 31, 2020 | $9.35M | -52.2% |
| Q4 FY2019 | Dec 31, 2019 | $12.58M | +21.2% |
| Q3 FY2019 | Sep 30, 2019 | $15.29M | +18.2% |
| Q2 FY2019 | Jun 30, 2019 | $17.06M | +12.0% |
| Q1 FY2019 | Mar 31, 2019 | $19.57M | +309.4% |
| Q4 FY2018 | Dec 31, 2018 | $10.38M | +43.8% |
| Q3 FY2018 | Sep 30, 2018 | $12.94M | +373.2% |
| Q2 FY2018 | Jun 30, 2018 | $15.24M | +306.9% |
| Q1 FY2018 | Mar 31, 2018 | $4.78M | +291.1% |
| Q4 FY2017 | Dec 31, 2017 | $7.22M | +134.1% |
| Q3 FY2017 | Sep 30, 2017 | $2.73M | -37.7% |
| Q2 FY2017 | Jun 30, 2017 | $3.75M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.22M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.08M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.39M | – |
See a number that looks wrong?